Cell volume restriction by mercury chloride reduces M1-like inflammatory response of bone marrow-derived macrophages

Yen-Chieh Chuang1, Shu-Yu Wu2, Yu-Chuan Huang3,4

  • 1Graduate Institute of Life Sciences, National Defense Medical Center, Taipei, Taiwan.

Frontiers in Pharmacology
|December 30, 2022
PubMed

Insights

Aquaporin (AQP) inhibition using mercury chloride (HgCl2) suppressed pro-inflammatory macrophage polarization. This AQP inhibitor reduced cell size changes and inflammatory signaling, promoting autophagy for mitochondrial repair.

Area of Science:

  • Immunology
  • Cell Biology
  • Molecular Biology

Background:

  • Macrophage polarization into M1 (pro-inflammatory) and M2 (anti-inflammatory) phenotypes is critical in inflammatory diseases.
  • Aquaporins (AQPs) are implicated in cell volume regulation and inflammatory responses.

Purpose of the Study:

  • To investigate the role of AQPs in macrophage polarization using the AQP inhibitor mercury chloride (HgCl2).
  • To elucidate the molecular mechanisms underlying HgCl2's effects on macrophage polarization.

Main Methods:

  • Bone marrow-derived macrophages were stimulated with lipopolysaccharides (LPSs).
  • AQP expression (AQP-1, AQP-9) and cell size changes were monitored.
  • The effects of HgCl2 on macrophage polarization, NF-κB and p38 MAPK pathways, IL-1β production, mitochondrial activity, reactive oxygen species (ROS) production, and autophagy were assessed.

Main Results:

  • LPSs increased AQP-1 and AQP-9 expression and cell size.
  • HgCl2 abolished LPS-induced cell size changes and suppressed M1 polarization.
  • HgCl2 inhibited NF-κB and p38 MAPK activation, reducing IL-1β production.
  • HgCl2 attenuated LPS-induced mitochondrial activation and ROS production.
  • HgCl2 promoted autophagy, indicated by increased LC3-II/LC3-I ratio and decreased PINK1 expression, suggesting mitochondrial recycling and restoration.

Conclusions:

  • The AQP inhibitor HgCl2 suppresses M1 macrophage polarization.
  • HgCl2 exerts its effects by restricting cell volume changes, inhibiting the p38 MAPK/NFκB pathway, and promoting autophagy.
  • These findings suggest a potential therapeutic mechanism for AQP inhibition in inflammatory conditions.